Your session is about to expire
← Back to Search
Dropless Regimen for Cataract Surgery
Study Summary
This trial is testing whether a single antibiotic and steroid drop given at the time of surgery can replace the current postoperative eye drop regimen for cataract surgery patients at Zuckerberg San Francisco General Hospital.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am approved for cataract surgery in both eyes due to significant vision loss.I have had eye surgery before.I need cataract surgery on both eyes at the same time.I have a history of advanced glaucoma.I have had an eye infection called endophthalmitis before.I am 18 years old or older.I have had swelling in the back of my eye within the last year.I have had eye pressure increases from steroids.I need both cataract and another eye surgery on the same day.
- Group 1: Standard Regimen
- Group 2: Dropless Regimen
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Standard Regimen been granted a U.S. Food and Drug Administration (FDA) stamp of approval?
"Our Power team rated Standard Regimen with a score of 3 due to its Phase 4 status, which indicates that this treatment has already been approved."
What is the primary aim of this clinical experiment?
"This clinical trial will track patient behaviour over the course of Post Operative Month 1 and its primary aim is to assess patient adherence with postoperative instructions. Secondary objectives include measuring Intraocular Pressure, Snellen Visual Acuity, and Clinically Significant Cystoid Macular Edema in order to draw conclusions on efficacy."
How many participants are being enrolled in this medical experiment?
"Affirmative. According to the information published on clinicaltrials.gov, this medical trial initiated recruitment process in May of 2022 and is actively seeking participants as of November 28th that same year. 70 individuals must be recruited from one location for successful completion of the study."
Is recruitment for this investigation still ongoing?
"Affirmative. The details published on clinicaltrials.gov demonstrate that this trial is actively recruiting suitable candidates, which was first posted on May 31st 2022 and has since been updated on November 28th 2022. 70 participants are required at one medical facility for enrollment in the study."
Share this study with friends
Copy Link
Messenger